News
Following a barrage of letters from President Donald Trump urging 17 large pharmaceutical companies to implement Most Favored ...
Our Drug Pricing and Market Access team tracks recent developments in healthcare reform, the Medicaid Drug Rebate Program, the 340B Program, ...
The U.S. government has been discussing with drugmakers how to raise overseas drug prices as President Donald Trump seeks to ...
The Trump administration has issued numerous pharma-focused executive orders, including “Lowering Drug Prices by Once Again Putting Americans ...
1d
Pharmaceutical Technology on MSNUncertainty around tariffs is a disincentive for pharma onshoring in the US
As tariffs on drug imports from the EU look set to alter pricing and manufacturing strategies, each entity needs to study its ...
As investors and industry watchers juggle the twin possibilities of pharmaceutical import tariffs and potential drug pricing ...
It’s a bad time to try to predict future pharmaceutical prices.
US President Donald Trump recently announced tariffs as high as 100% on certain semiconductor products. Although South Korea ...
Aside from the MFN order, President Trump is also in the process of negotiating tariffs with countries all over the world. It ...
President Donald Trump has sent letters to pharmaceutical companies, aiming to compel them to lower drug prices in the US to ...
Late last week, President Donald Trump sent letters to 17 pharmaceutical companies pressing them to deliver on his May ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results